Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 10, Number 12—December 2004


Crimean-Congo Hemorrhagic Fever, Mauritania

Pierre Nabeth*Comments to Author , Dah Ould Cheikh†, Baidy Lo‡, Ousmane Faye*, Idoumou Ould Mohamed Vall†, Mbayame Niang*, Bocar Wague†, Djibril Diop‡, Mawlouth Diallo*, Boubacar Diallo§, Ousmane Madiagne Diop*, and François Simon*
Author affiliations: *Institut Pasteur de Dakar, Dakar, Senegal; †Ministère de la Santé et des Affaires Sociales, Nouakchott, Mauritania; ‡Centre National d’Hygiène, Nouakchott, Mauritania; and; §Centre National d’Elevage et de Recherches Vétérinaires, Nouakchott, Mauritania

Main Article

Table 1

Distribution of Crimean-Congo hemorrhagic fever cases that were confirmed by serologic test, Mauritania, February–August 2003

Laboratory testa No. positive (%)b
ELISA-IgM 22 (64.7)
RT-PCR 1 (2.9)
Isolation 2 (5.9)
ELISA-IgM + RT-PCR 6 (17.6)
ELISA-IgM + RT-PCR + isolation 3 (8.8)
Total 34 (100.0)

aELISA, enzyme-linked immunosorbent assay; RT-PCR, reverse transcription–polymerase chain reaction; Ig, immunoglobulin.
bAn additional 4 persons met the criteria for having a probable case but died before sampling, so their cases could not be confirmed with serologic tests; according to the case definition, these persons were considered case-patients, which brings the total number of cases to 38.

Main Article

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO